{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "80426-042",
      "generic_name": "Risedronate Sodium",
      "labeler_name": "PEL HEALTHCARE LLC",
      "active_ingredients": [
        {
          "name": "RISEDRONATE SODIUM MONOHYDRATE",
          "strength": "150 mg/1"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "80426-042-01",
          "description": "75000 TABLET, FILM COATED in 1 CONTAINER (80426-042-01)",
          "marketing_start_date": "12-DEC-16"
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "7061ce8f-4b8f-4557-98c3-804da00d84fb",
      "product_type": "DRUG FOR FURTHER PROCESSING",
      "marketing_start_date": "20161212",
      "product_id": "80426-042_7061ce8f-4b8f-4557-98c3-804da00d84fb",
      "brand_name_base": null
    }
  ]
}